Brochure | January 20, 2022

Controlled Substances

Source: Cambrex
iStock-1298328343-pill-tablet-bottle-prescription-OSD-oral

Development, manufacture & distribution of controlled substances

Cambrex holds US Drug Enforcement Agency (DEA) licenses for process research, development, manufacturing and importation of Schedule I to IV controlled substances.

We are one of a limited number of US companies authorized by the DEA to import narcotic raw materials at commercial scale and have been successfully manufacturing highly potent opioids since 2005.

  • Routinely manufacture and distribute commercial quantities of Schedule I to IV controlled substances throughout the world
  • Drug Master Files (DMF) for >20 controlled substances
  • Controlled substances R&D
VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Drug Discovery Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: